Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH81839FSA
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Torrent Pharmaceuticals Ltd (TORNTPHARM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd Key Recent Developments

Jul 26,2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company

Dec 11,2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad

Jul 31,2017: Torrent Pharma announces Q1 FY 2017-18 Results

Jul 22,2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company

May 26,2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Torrent Pharmaceuticals Ltd-Key Facts 5

Torrent Pharmaceuticals Ltd-Key Employees 6

Torrent Pharmaceuticals Ltd-Key Employee Biographies 7

Torrent Pharmaceuticals Ltd-Major Products and Services 8

Torrent Pharmaceuticals Ltd-History 9

Torrent Pharmaceuticals Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 14

Company Overview 14

Torrent Pharmaceuticals Ltd-Business Description 15

Torrent Pharmaceuticals Ltd-Corporate Strategy 16

Torrent Pharmaceuticals Ltd-SWOT Analysis 17

SWOT Analysis-Overview 17

Torrent Pharmaceuticals Ltd-Strengths 17

Torrent Pharmaceuticals Ltd-Weaknesses 18

Torrent Pharmaceuticals Ltd-Opportunities 19

Torrent Pharmaceuticals Ltd-Threats 20

Torrent Pharmaceuticals Ltd-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Torrent Pharmaceuticals Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Jul 26, 2018: Torrent Pharmaceuticals: Intimation of cessation of director of the company 32

Dec 11, 2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad 33

Dec 11, 2017: Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad 35

Jul 31, 2017: Torrent Pharma announces Q1 FY 2017-18 Results 37

Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 39

May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Torrent Pharmaceuticals Ltd, Performance Chart (2014-2018) 26

Torrent Pharmaceuticals Ltd, Ratio Charts 28

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

List of Tables

Torrent Pharmaceuticals Ltd, Key Facts 5

Torrent Pharmaceuticals Ltd, Key Employees 6

Torrent Pharmaceuticals Ltd, Key Employee Biographies 7

Torrent Pharmaceuticals Ltd, Major Products and Services 8

Torrent Pharmaceuticals Ltd, History 9

Torrent Pharmaceuticals Ltd, Other Locations 11

Torrent Pharmaceuticals Ltd, Subsidiaries 11

Torrent Pharmaceuticals Ltd, Key Competitors 21

Torrent Pharmaceuticals Ltd, Ratios based on current share price 22

Torrent Pharmaceuticals Ltd, Annual Ratios 23

Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...1) 24

Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...2) 25

Torrent Pharmaceuticals Ltd, Interim Ratios 27

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Torrent Pharmaceuticals Ltd, Recent Deals Summary 31

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sanofi India Ltd

RPG Life Sciences Ltd

Panacea Biotec Ltd

NGL Fine-chem Ltd

Natco Pharma Ltd

Intas Pharmaceuticals Ltd

Granules India Ltd

Allied Chemicals and Pharmaceuticals Pvt Ltd

Ajanta Pharma Ltd

Torrent Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8990
Site License
USD 250 INR 17980
Corporate User License
USD 375 INR 26970

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com